{"id":"NCT00346333","sponsor":"National Eye Institute (NEI)","briefTitle":"Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A","officialTitle":"Randomized Clinical Trial for Retinitis Pigmentosa","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-07","primaryCompletion":"2008-12","completion":"2008-12","firstPosted":"2006-06-29","resultsPosted":"2014-01-31","lastUpdate":"2014-01-31"},"enrollment":240,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Retinitis Pigmentosa"],"interventions":[{"type":"DRUG","name":"Lutein","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Cornstarch control","otherNames":[]}],"arms":[{"label":"Lutein plus 15,000 IU/d Vitamin A","type":"EXPERIMENTAL"},{"label":"Control plus 15,000 IU/d Vitamin A","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this trial is to determine whether lutein in addition to vitamin A will slow the course of retinitis pigmentosa.","primaryOutcome":{"measure":"Central Visual Field (vf) Change Assessed Using the 30-2 Program of the Humphrey Field Analyzer (HFA).","timeFrame":"assessed at each of 4 annual visits after baseline","effectByArm":[{"arm":"Control Plus Vitamin A","deltaMin":-51.5,"sd":3.2},{"arm":"Lutein Plus Vitamin A","deltaMin":-49.6,"sd":3.3}],"pValues":[{"comp":"OG000 vs OG001","p":"0.66"},{"comp":"OG000 vs OG001","p":"0.52"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":21,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["20385935","37261916"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":121},"commonTop":[]}}